Skip to content

Effects of lowering blood glucose on T cell activation in fat tissue

Effects of lowering blood glucose on T Lymphocyte activation in human adipose tissue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87451268
Enrollment
22
Registered
2013-12-20
Start date
2014-01-06
Completion date
Unknown
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care Research Network for England

Interventions

Diet and activity modification, For 10 days, participants will be instructed to consume a glucose lowering diet. This will involve modifications to their normal diet such as replacing high GI foods wi

Sponsors

University of Bath (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or postmenopausal* female 2. Aged between 45 to 65years 3. Waist circumference >94cm (males) or >80cm (females) 4. Weight stable for more than 3 months (no change in weight +/- 3%) Non-smoker Group 1 participants will be overweight with 'normal glucose tolerance' as defined by 2h oral glucose tolerance test (blood glucose 7.8 mmol/L but <11.1mmol/L at 2h post 75g glucose drink) *postmenopausal defined as no menstruation for at least 1 year (Witteman, Grobbee et al. 1989).; Target Gender: Male & Female; Upper Age Limit 65 years ; Lower Age Limit 45 years

Exclusion criteria

Exclusion criteria: 1. Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia 2. Taking medications that may influence lipid or carbohydrate metabolism or immune system function 3. Perform >150minutes/week moderate intensity exercise

Design outcomes

Primary

MeasureTime frame
T cell number and activation in adipose tissue; Timepoint(s): Pre and post intervention

Secondary

MeasureTime frame
1. Adipose tissue cytokine secretion; Timepoint(s): Pre and post intervention 2. Adipose tissue gene expression; Timepoint(s): Pre and post intervention 3. Macrophage number and activation in adipose tissue; Timepoint(s): Pre and post intervention 4. T Lymphocyte and monocyte numbers and activation in blood; Timepoint(s): Pre and post intervention

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026